other material
confidence high
sentiment neutral
materiality 0.30
Protagenic Therapeutics exchanges 459,420 warrants for 367,544 shares at 0.8 ratio
Protagenic Therapeutics, Inc.new
- Warrant Exchange Agreement with unaffiliated holder to cancel 459,420 warrants for 367,544 common shares.
- Exchange relies on Section 3(a)(9) exemption; shares issued without restrictive legends.
- Transaction to be completed within six months of May 20, 2025.
- Net reduction of 91,876 potential shares outstanding compared to exercise of warrants.